A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV‐1 protease

@article{Vega2004ASA,
  title={A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV‐1 protease},
  author={Sonia Vega and L. Kang and A. Vel{\'a}zquez-Campoy and Y. Kiso and L. M. Amzel and E. Freire},
  journal={Proteins: Structure},
  year={2004},
  volume={55}
}
  • Sonia Vega, L. Kang, +3 authors E. Freire
  • Published 2004
  • Chemistry, Medicine
  • Proteins: Structure
  • The efficacy of HIV‐1 protease inhibition therapies is often compromised by the appearance of mutations in the protease molecule that lower the binding affinity of inhibitors while maintaining viable catalytic activity and substrate affinity. The V82F/I84V double mutation is located within the binding site cavity and affects all protease inhibitors in clinical use. KNI‐764, a second‐generation inhibitor currently under development, maintains significant potency against this mutation by… CONTINUE READING
    48 Citations

    Topics from this paper

    Suppression of HIV-1 protease inhibitor resistance by phosphonate-mediated solvent anchoring.
    • 45
    Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations
    • 105
    • Highly Influenced
    • PDF
    Adaptive inhibitors of the HIV-1 protease.
    • 126
    Molecular dynamics simulations of HIV-1 protease complexed with saquinavir
    • 1
    • PDF

    References

    SHOWING 1-10 OF 36 REFERENCES
    Overcoming drug resistance in HIV‐1 chemotherapy: The binding thermodynamics of Amprenavir and TMC‐126 to wild‐type and drug‐resistant mutants of the HIV‐1 protease
    • 95
    The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design.
    • 138
    Thermodynamic dissection of the binding energetics of KNI‐272, a potent HIV‐1 protease inhibitor
    • 85
    The structural stability of the HIV-1 protease.
    • 154